I'll defer to Ohm to speculate. I know he's stated something to the effect that he'd like to see the full results or setup of the study. I don't think anything has ever been attributed to a bad batch of LL though. If we were to the point where the product on hand had gone bad then we wouldn't have seen the awesome results in the MASH study, IMO. Those studies were going concurrently. We would also pretty much be out of product and not able to run trials, so we'd effectively be out of business, so no, I don't think that's it.